Your trusted health, nutrition, and personalized lifestyle medicine resource

Endocannabinoid System (ECS) Signaling in Depressive Disorders

Cecilia Hillard, PhD

 

In this interview, Cecilia Hillard, PhD discusses endocannabinoid system (ECS) signaling in depressive disorders. Dr. Hillard describes the effect of exercise on the ECS, and how this may underpin some of the benefits of exercise in patients with depression and other mood disorders. Dr. Hillard discusses emerging results in patients with post-traumatic stress disorder (PTSD) which show a different picture, and ends with a discussion on what we know about the role that the endocannabinoid receptors (CB1 and CB2) play in depression.

Cecilia Hillard, PhD is Professor of Pharmacology and Toxicology, Director of the Neuroscience Research Center, Associate Dean for Research at Medical College of Wisconsin

From the 16th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2019 in St Petersburg, Florida

Metagenics Institute is a trusted, peer-to-peer, evidence-based educational resource for nutrition and personalized medicine.
At Metagenics Institute, we translate credible research with scientific integrity into innovative and actionable clinical
decision-making. Metagenics Institute supports a diverse practitioner base to optimize patient outcomes by shifting existing paradigms in healthcare. Our mission is to transform healthcare by inspiring and educating practitioners, and their patients, about personalized lifestyle medicine.

Sponsored by
© 2021 Metagenics Institute. All Rights Reserved
Stay up-to-date with COVID-19VIEW NOW
+